Utpal Koppikar - Net Worth and Insider Trading
Utpal Koppikar Net Worth
The estimated net worth of Utpal Koppikar is at least $116,171 dollars as of 2024-11-13. Utpal Koppikar is the CFO of Atara Biotherapeutics Inc and owns about 7,279 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $84,946. Utpal Koppikar is also the Director of C4 Therapeutics Inc and owns about 5,667 shares of C4 Therapeutics Inc (CCCC) stock worth over $31,225. Details can be seen in Utpal Koppikar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Utpal Koppikar has not made any transactions after 2023-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Utpal Koppikar
Utpal Koppikar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Utpal Koppikar owns 2 companies in total, including Atara Biotherapeutics Inc (ATRA) , and C4 Therapeutics Inc (CCCC) .
Click here to see the complete history of Utpal Koppikar’s form 4 insider trades.
Insider Ownership Summary of Utpal Koppikar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2023-03-02 | Chief Financial Officer |
| CCCC | C4 Therapeutics Inc | 2023-02-08 | director |
Utpal Koppikar Latest Holdings Summary
Utpal Koppikar currently owns a total of 2 stocks. Among these stocks, Utpal Koppikar owns 7,279 shares of Atara Biotherapeutics Inc (ATRA) as of March 2, 2023, with a value of $84,946 and a weighting of 73.12%. Utpal Koppikar also owns 5,667 shares of C4 Therapeutics Inc (CCCC) as of February 8, 2023, with a value of $31,225 and a weighting of 26.88%.
Latest Holdings of Utpal Koppikar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2023-03-02 | 7,279 | 11.67 | 84,946 |
| CCCC | C4 Therapeutics Inc | 2023-02-08 | 5,667 | 5.51 | 31,225 |
Holding Weightings of Utpal Koppikar
Utpal Koppikar Form 4 Trading Tracker
According to the SEC Form 4 filings, Utpal Koppikar has made a total of 21 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Atara Biotherapeutics Inc is the sale of 275 shares on March 2, 2023, which brought Utpal Koppikar around $24,942.
According to the SEC Form 4 filings, Utpal Koppikar has made a total of 1 transactions in C4 Therapeutics Inc (CCCC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in C4 Therapeutics Inc is the acquisition of 5,667 shares on February 8, 2023, which cost Utpal Koppikar around $31,735.
Insider Trading History of Utpal Koppikar
- 1
Utpal Koppikar Trading Performance
GuruFocus tracks the stock performance after each of Utpal Koppikar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Utpal Koppikar is -26.7%. GuruFocus also compares Utpal Koppikar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Utpal Koppikar within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Utpal Koppikar's insider trading performs compared to the benchmark.
Performance of Utpal Koppikar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.92 | | | | | |
| Relative Return to S&P 500(%) | -3.77 | | | | | |
Utpal Koppikar Ownership Network
Ownership Network List of Utpal Koppikar
Ownership Network Relation of Utpal Koppikar
Utpal Koppikar Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Utpal Koppikar is the Chief Financial Officer of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Utpal Koppikar made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Utpal Koppikar Mailing Address
Above is the net worth, insider trading, and ownership report for Utpal Koppikar. You might contact Utpal Koppikar via mailing address: C/o Atara Biotherapeutics, Inc., 611 Gateway Blvd, Suite 900, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
